Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by general360on Dec 21, 2021 11:31am
166 Views
Post# 34250636

RE:Screening

RE:Screeningprecisely! getting up there and throwing out the fact we've been screening since last week - WTF have you been doing for the past 2 months since we received eihics approvals? apparently sitting on butt doing jack-all? what about since Feb since we're cleared to begin immediate trials?!  what's after screening?  courting?  dancing?

getting up and telling me great,grand wonderful, we've started screening finally...after the delays, thats of ZERO comfort cause i'm sure you'll find another step in between screening and ramming pills down someone's throat...
woulda preferred a trial-101 and a detailed breakdown of why we're @ where we're @...

academic and political delays?  what sort of delay is Feb approval to begin immediate trials, then Dec still waiting?  or is that an academic delay?  perhaps academic delays may resolve themselves, but i dont think polititcal delays go away....

why oh why can't we get a straight answer....

of the 24 trades made today in the first almost 90m, 18 of them have been for less than 10 shares per trade....painting the tape red today?  whats up w/ the weak volume?  back to the usual no trading?
<< Previous
Bullboard Posts
Next >>